Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-014755
Filing Date
2022-08-04
Accepted
2022-08-04 16:14:40
Documents
67
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cdak-20220630.htm   iXBRL 10-Q 2547984
2 EX-10.1 cdak-ex10_1.htm EX-10.1 41689
3 EX-31.1 cdak-ex31_1.htm EX-31.1 21680
4 EX-31.2 cdak-ex31_2.htm EX-31.2 21872
5 EX-32.1 cdak-ex32_1.htm EX-32.1 24853
  Complete submission text file 0000950170-22-014755.txt   9380373

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cdak-20220630_lab.xml EX-101.LAB 503050
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cdak-20220630_cal.xml EX-101.CAL 47896
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cdak-20220630.xsd EX-101.SCH 66250
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cdak-20220630_pre.xml EX-101.PRE 342365
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cdak-20220630_def.xml EX-101.DEF 192540
61 EXTRACTED XBRL INSTANCE DOCUMENT cdak-20220630_htm.xml XML 1845578
Mailing Address 35 CAMBRIDGEPARK DRIVE SUITE 500 CAMBRIDGE MA 02140
Business Address 35 CAMBRIDGEPARK DRIVE SUITE 500 CAMBRIDGE MA 02140 617-949-4100
Codiak BioSciences, Inc. (Filer) CIK: 0001659352 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39615 | Film No.: 221136754
SIC: 2836 Biological Products, (No Diagnostic Substances)